Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Population-Based, Cause-Specific Risk of Non-Lymphoma Deaths Among 20,491 Adults with Classical Hodgkin Lymphoma (cHL) Treated with Initial Chemotherapy in the United States, 2000-2015

Graca M. Dores, MD, Rochelle E. Curtis, MA, Nicole H. Dalal, BA, Martha S. Linet, MD MPH, Lindsay M. Morton, PhD

Blood (2019) 134 (Supplement_1): 4034.

https://doi.org/10.1182/blood-2019-124831

Published: 2019

Journal Articles

Risk Factors and Trends for Incidence of Acute Coronary Syndrome after Hematopoietic Stem Cell Transplant - a 15-Year Experience with National Inpatient Sample

Jasdeep Singh Sidhu, MBBS, Jeevanjot Kaur Virk, MBBS, Shivani Handa, MBBS, Amrendra Mandal, Sridevi Rajeeve, MD

Blood (2019) 134 (Supplement_1): 4564.

https://doi.org/10.1182/blood-2019-127487

Published: 2019

Journal Articles

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Muhammad Zain Farooq, MD MBBS, Prasanth Lingamaneni, Muhammad Saad Farooq, MBBS, Aakash Putta, MD MBBS, Sheeba Ba Aqeel, VV Pavan Kedar Mukthinuthalapati, Ankit Mangla, MBBS, MD, Paul Rubinstein, MD

Blood (2019) 134 (Supplement_1): 4963.

https://doi.org/10.1182/blood-2019-129607

Published: 2019

Journal Articles

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Baba PD Inusa, MD, Adlette Inati, MD, Philip Maes, MD, Jessie Githanga, MBChB, MMed, Miguel R. Abboud, MD, Maurizio Miano, Elena Cela, Videlis Nduba, Mohammad Niazi, Magnus Åstrand, Kevin Persson, Anders Rikard Berggren, MD PhD, Glenn Carlson, MD

Blood (2019) 134 (Supplement_1): 1005.

https://doi.org/10.1182/blood-2019-129855

Published: 2019

Journal Articles

Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study

Pinkal Desai, MDMPH, Samuel Handelman, PhD, Alan Wu, MPH, Paul J Christos, Dr.P.H., M.S., Sangmin Lee, MD, Michael B. Samuel, MD, Ellen K. Ritchie, MD, Monica L. Guzman, PhD, Rebecca Jackson, Duane C. Hassane, PhD, Joann Manson, Alexander Reiner, MD, Michael S. Simon, MDMPH, Gail J. Roboz, MD

Blood (2019) 134 (Supplement_1): 1199.

https://doi.org/10.1182/blood-2019-131862

Published: 2019

Journal Articles

Inflammasome Activation Promotes Deep Vein Thrombosis through Pyroptosis

Yan Zhang, Guoying Zhang, Cui Jian, Congqing Wu, PhD, Nigel Mackman, PhD, Susan Smyth, MD PhD, Yinan Wei, Zhenyu Li, PhD

Blood (2019) 134 (Supplement_1): 3644.

https://doi.org/10.1182/blood-2019-130439

Published: 2019

Journal Articles

Trends in Age-Adjusted Mortality Rates for Pulmonary Embolism in the United States, 1999-2017

Karlyn A. Martin, MD, Rebecca Molsberry, MPH, Sadiya Khan, MD MSc

Blood (2019) 134 (Supplement_1): 3452.

https://doi.org/10.1182/blood-2019-128934

Published: 2019

Journal Articles

Net Clinical Benefit of Low Dose Rivaroxaban in Coronary Heart Disease: A Systematic Review and Meta-Analysis

Muhammad Zain Farooq, MD MBBS, Muhammad Saad Farooq, MBBS, Saira Farid, MD, Talha Aijaz, MD, Ishaan Vohra, MD, Vatsala Katiyar, MD, Ankit Mangla, MBBS,MD

Blood (2019) 134 (Supplement_1): 3662.

https://doi.org/10.1182/blood-2019-121899

Published: 2019

Journal Articles

Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS)

Diego Adrianzen Herrera, MD, Kith Pradhan, PhD, Rosebella Snyder, MD, Siddharth Karanth, MBBS, MPH, DrPH, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS, Santosh Murthy, MD MPH, Amit Verma, MBBS, Aditi Shastri, MD

Blood (2019) 134 (Supplement_1): 336.

https://doi.org/10.1182/blood-2019-123317

Published: 2019

Journal Articles

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Brett Slajus, Yevgeniy Brailovsky, DO, Trung Phan, Iman Darwish, Jawed Fareed, PhD, Amir Darki, MD MSc

Blood (2019) 134 (Supplement_1): 2103.

https://doi.org/10.1182/blood-2019-127425

Published: 2019

Journal Articles

Clinical and Molecular Variables Associated with Atherosclerotic Vascular Disease in Myelodysplastic Syndromes

Mark G. Faber, DO, Amanda Przespolewski, DO, Jeffrey Baron, PharmD, Tara Cronin, BA, Wei Tan, MS, James E. Thompson, MD, Eunice S. Wang, MD, Elizabeth A. Griffiths, MD, Swapna Thota, MD

Blood (2018) 132 (Supplement 1): 4366.

https://doi.org/10.1182/blood-2018-99-110846

Published: 2018

Journal Articles

Estimating the Burden of Hospital-Acquired Venous Thromboembolism: The Argument for Implementation of Mandatory Risk Reduction Strategies

Barry Kevane, MB, PhD, Mary Day, PhD, Noirin Bannon, Leo Lawler, MB, Tomas Breslin, MB, Claire Andrews, MB, Howard Johnson, PhD, Michael Fitzpatrick, Karen Murphy, MD, Olivia Mason, MSc, Sarah Kelliher, MB, Annemarie O'Neill, Fionnuala Donohue, Fionnuala Ni Ainle, MD PhD

Blood (2018) 132 (Supplement 1): 3515.

https://doi.org/10.1182/blood-2018-99-112143

Published: 2018

Journal Articles

Myelodysplastic Syndromes (MDS) Are an Independent Risk Factor for an Earlier Onset of Myocardial Infarction and Increased Mortality from Cardiovascular Disease (CVD)

Blood (2018) 132 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2018-99-115613

Published: 2018

Journal Articles

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

Jan Beyer-Westendorf, MD, Luise Tittl, Christiane Naue, MD, Sandra Marten, MD

Blood (2018) 132 (Supplement 1): 422.

https://doi.org/10.1182/blood-2018-99-118081

Published: 2018

Journal Articles

Predictive Value of Gradual Change in Renal Function on Vasculopathy Related Complications and Mortality in Patients with Sickle Cell Disease

Bart J. Biemond, MD PhD, Weel Elsita, Charlotte F.J. Van Tuijn, MPH, Erfan Nur, MD PhD, Liffert Vogt, MDPhD

Blood (2017) 130 (Supplement 1): 986.

https://doi.org/10.1182/blood.V130.Suppl_1.986.986

Published: 2017

Journal Articles

Population Trends in Incidence of Second Malignant Neoplasm and Cause-Specific Mortality in Patients with Multiple Myeloma

Luciano J. Costa, MD PhD, Kelly N. Godby, MD, Saurabh Chhabra, MD, Robert Frank Cornell, MD, Parameswaran Hari, MD MRCP, MS, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 682.

https://doi.org/10.1182/blood.V130.Suppl_1.682.682

Published: 2017

Journal Articles

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Maria Almudena Garcia Ruiz, Marta Rivas Luque, Pablo Romero Garcia, MDCINE Resident, Manuel Jurado, MD PhD

Blood (2017) 130 (Supplement 1): 4920.

https://doi.org/10.1182/blood.V130.Suppl_1.4920.4920

Published: 2017

Journal Articles

Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms

Tiziano Barbui, MD, Valerio De Stefano, MD, Alessandra Carobbio, MSc, Vincenzo Di Lazzaro, MD, Paola Guglielmelli, MD PhD, Giuseppe Gaetano Loscocco, MD, Alessandra Iurlo, MD PhD, Daniele Cattaneo, MD, Agostino Cortelezzi, Prof, Silvia Betti, MD, Elena Rossi, MD, Maria Chiara Finazzi, MD, Guido Finazzi, MD, Bruno Censori, MD, Mario Cazzola, MD, Elisa Rumi, MD, Marta Bellini, MD, Francisco Cervantes, MD, Eduardo Arellano-Rodrigo, MD, Elena Elli, MD, Maria Luigia Randi, MD, Irene Bertozzi, MD, Martin Griesshammer, MD, Parvis Sadjadian, MD, Francesca Palandri, PhD MD, Nicola Vianelli, Massimiliano Bonifacio, MD, Luigi Scaffidi, Juan Carlos Hernandez-Boluda, MD, Montse Gomez, MD, Emma Cacciola, MD, Rossella Rosari Cacciola, MD, Palova Miroslava, MD, Giuseppe Carli, MD, Eloise Beggiato, MD, Martin H Ellis, MD, Caterina Musolino, MD, Gianluca Gaidano, MD PhD, Davide Rapezzi, MD, Alessia Tieghi, MD, Francesca Lunghi, MD, Alessandro M. Vannucchi

Blood (2017) 130 (Supplement 1): 202.

https://doi.org/10.1182/blood.V130.Suppl_1.202.202

Published: 2017

Journal Articles

Second Primary Malignancies and Cardiovascular Mortality in Hodgkin disease Survivors — a Surveillance, Epidemiology, and End Results Registry Database Study

Upama Giri, Kruti Patel, DO, Michael G. Martin, MD

Blood (2017) 130 (Supplement 1): 1513.

https://doi.org/10.1182/blood.V130.Suppl_1.1513.1513

Published: 2017

Journal Articles

The Widow Maker: A National Inpatient Sample Study of Health Care Utilization Costs for Cardiovascular Complications Patients Diagnosed with Non-Hodgkin's Lymphoma from 2000-2014

Ragisha Gopalakrishnan, MD, Shruti Chaturvedi, MBBS,MS

Blood (2017) 130 (Supplement 1): 4696.

https://doi.org/10.1182/blood.V130.Suppl_1.4696.4696

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Population-Based, Cause-Specific Risk of Non-Lymphoma Deaths Among 20,491 Adults with Classical Hodgkin Lymphoma (cHL) Treated with Initial Chemotherapy in the United States, 2000-2015

Risk Factors and Trends for Incidence of Acute Coronary Syndrome after Hematopoietic Stem Cell Transplant - a 15-Year Experience with National Inpatient Sample

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study

Inflammasome Activation Promotes Deep Vein Thrombosis through Pyroptosis

Trends in Age-Adjusted Mortality Rates for Pulmonary Embolism in the United States, 1999-2017

Net Clinical Benefit of Low Dose Rivaroxaban in Coronary Heart Disease: A Systematic Review and Meta-Analysis

Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS)

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Clinical and Molecular Variables Associated with Atherosclerotic Vascular Disease in Myelodysplastic Syndromes

Estimating the Burden of Hospital-Acquired Venous Thromboembolism: The Argument for Implementation of Mandatory Risk Reduction Strategies

Myelodysplastic Syndromes (MDS) Are an Independent Risk Factor for an Earlier Onset of Myocardial Infarction and Increased Mortality from Cardiovascular Disease (CVD)

NOAC Therapy Is Also Effective and Safe in Patients Older Than 80 Years — Results of the Prospective Dresden NOAC Registry (NCT01588119)

Predictive Value of Gradual Change in Renal Function on Vasculopathy Related Complications and Mortality in Patients with Sickle Cell Disease

Population Trends in Incidence of Second Malignant Neoplasm and Cause-Specific Mortality in Patients with Multiple Myeloma

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms

Second Primary Malignancies and Cardiovascular Mortality in Hodgkin disease Survivors — a Surveillance, Epidemiology, and End Results Registry Database Study

The Widow Maker: A National Inpatient Sample Study of Health Care Utilization Costs for Cardiovascular Complications Patients Diagnosed with Non-Hodgkin's Lymphoma from 2000-2014

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only